HK1006726A1 - T-cell lymphoma cdna clones - Google Patents
T-cell lymphoma cdna clonesInfo
- Publication number
- HK1006726A1 HK1006726A1 HK98106035A HK98106035A HK1006726A1 HK 1006726 A1 HK1006726 A1 HK 1006726A1 HK 98106035 A HK98106035 A HK 98106035A HK 98106035 A HK98106035 A HK 98106035A HK 1006726 A1 HK1006726 A1 HK 1006726A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- novel
- expressed
- proteins
- cell
- dna sequences
- Prior art date
Links
- 206010042971 T-cell lymphoma Diseases 0.000 title 1
- 208000027585 T-cell non-Hodgkin lymphoma Diseases 0.000 title 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 4
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000035160 transmembrane proteins Human genes 0.000 abstract 4
- 108091005703 transmembrane proteins Proteins 0.000 abstract 4
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 230000013020 embryo development Effects 0.000 abstract 1
- 210000004837 gut-associated lymphoid tissue Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 230000002611 ovarian Effects 0.000 abstract 1
- 210000004989 spleen cell Anatomy 0.000 abstract 1
- 210000001541 thymus gland Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50968490A | 1990-04-13 | 1990-04-13 | |
| PCT/US1991/002518 WO1991016430A1 (en) | 1990-04-13 | 1991-04-12 | NOVEL T-CELL LYMPHOMA cDNA CLONES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1006726A1 true HK1006726A1 (en) | 1999-03-12 |
Family
ID=24027673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98106035A HK1006726A1 (en) | 1990-04-13 | 1998-06-23 | T-cell lymphoma cdna clones |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US5312733A (xx) |
| EP (1) | EP0527813B1 (xx) |
| JP (1) | JPH05506989A (xx) |
| KR (1) | KR100212371B1 (xx) |
| AT (1) | ATE141105T1 (xx) |
| AU (1) | AU664535B2 (xx) |
| CA (1) | CA2080018C (xx) |
| DE (1) | DE69121240T2 (xx) |
| DK (1) | DK0527813T3 (xx) |
| ES (1) | ES2093100T3 (xx) |
| FI (1) | FI108037B (xx) |
| GR (1) | GR3021478T3 (xx) |
| HK (1) | HK1006726A1 (xx) |
| IE (1) | IE75903B1 (xx) |
| IL (1) | IL97775A (xx) |
| NO (1) | NO307341B1 (xx) |
| NZ (1) | NZ237669A (xx) |
| PT (1) | PT97355B (xx) |
| RU (1) | RU2116346C1 (xx) |
| SA (1) | SA92120348B1 (xx) |
| WO (1) | WO1991016430A1 (xx) |
| ZA (1) | ZA912489B (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6784163B1 (en) * | 1990-04-13 | 2004-08-31 | Macleod Carol L. | Inhibition of cationic amino acid transporter protein and uses thereof |
| WO1994004567A1 (en) * | 1992-08-21 | 1994-03-03 | La Jolla Cancer Research Foundation | A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids |
| AU6827094A (en) * | 1993-05-07 | 1994-12-12 | Immunex Corporation | Cytokine designated 4-1bb ligand and human receptor that binds thereto |
| US7211259B1 (en) | 1993-05-07 | 2007-05-01 | Immunex Corporation | 4-1BB polypeptides and DNA encoding 4-1BB polypeptides |
| US7138500B1 (en) | 1993-05-07 | 2006-11-21 | Immunex Corporation | Antibodies to human 4-1BB |
| US5866329A (en) * | 1995-09-27 | 1999-02-02 | Demetriou; Achilles A. | Method and probe for detection of gene associated with liver neoplastic disease |
| US5861248A (en) * | 1996-03-29 | 1999-01-19 | Urocor, Inc. | Biomarkers for detection of prostate cancer |
| US6627199B1 (en) * | 1999-07-09 | 2003-09-30 | Amgen Inc | Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family |
| US20030096355A1 (en) * | 1999-07-09 | 2003-05-22 | Ke Zhang | Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family |
| CA2381284A1 (en) * | 1999-08-04 | 2001-02-15 | Amgen Inc. | Fhm, a novel member of the tnf ligand supergene family |
| AU6517800A (en) * | 1999-08-04 | 2001-03-05 | Amgen, Inc. | Ntr3, a member of the tnf-receptor supergene family |
| WO2003027321A2 (en) * | 2001-09-24 | 2003-04-03 | University Of Aarhus | Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin |
| US20100021953A1 (en) * | 2005-08-03 | 2010-01-28 | Astrazeneca Ab | Method for Identifying an Agent that Modulates Arginine Transport in a Chondrocyte |
| CA2629532C (en) | 2005-11-18 | 2016-08-09 | University Health Network | Method of expanding double negative t cells |
| SG176303A1 (en) | 2009-06-10 | 2012-01-30 | Stephen Sanig Res Inst Ltd | Methods of generating cells exhibiting phenotypic plasticity |
-
1991
- 1991-04-03 NZ NZ237669A patent/NZ237669A/xx unknown
- 1991-04-04 ZA ZA912489A patent/ZA912489B/xx unknown
- 1991-04-04 IL IL97775A patent/IL97775A/en not_active IP Right Cessation
- 1991-04-11 US US07/686,322 patent/US5312733A/en not_active Expired - Lifetime
- 1991-04-12 CA CA002080018A patent/CA2080018C/en not_active Expired - Fee Related
- 1991-04-12 IE IE125091A patent/IE75903B1/en not_active IP Right Cessation
- 1991-04-12 AT AT91908417T patent/ATE141105T1/de not_active IP Right Cessation
- 1991-04-12 ES ES91908417T patent/ES2093100T3/es not_active Expired - Lifetime
- 1991-04-12 PT PT97355A patent/PT97355B/pt not_active IP Right Cessation
- 1991-04-12 WO PCT/US1991/002518 patent/WO1991016430A1/en active IP Right Grant
- 1991-04-12 JP JP91508037A patent/JPH05506989A/ja active Pending
- 1991-04-12 DK DK91908417.8T patent/DK0527813T3/da active
- 1991-04-12 DE DE69121240T patent/DE69121240T2/de not_active Expired - Fee Related
- 1991-04-12 EP EP91908417A patent/EP0527813B1/en not_active Expired - Lifetime
- 1991-04-12 KR KR1019920702504A patent/KR100212371B1/ko not_active IP Right Cessation
- 1991-04-12 AU AU77457/91A patent/AU664535B2/en not_active Ceased
- 1991-04-12 RU SU5053186/13A patent/RU2116346C1/ru not_active IP Right Cessation
-
1992
- 1992-01-22 SA SA92120348A patent/SA92120348B1/ar unknown
- 1992-10-08 NO NO923918A patent/NO307341B1/no not_active IP Right Cessation
- 1992-10-09 FI FI924575A patent/FI108037B/fi not_active IP Right Cessation
-
1993
- 1993-01-11 US US08/002,999 patent/US5440017A/en not_active Expired - Fee Related
-
1996
- 1996-10-24 GR GR960402837T patent/GR3021478T3/el unknown
-
1998
- 1998-06-23 HK HK98106035A patent/HK1006726A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR930700657A (ko) | 1993-03-15 |
| AU7745791A (en) | 1991-11-11 |
| PT97355B (pt) | 1998-08-31 |
| RU2116346C1 (ru) | 1998-07-27 |
| WO1991016430A1 (en) | 1991-10-31 |
| NZ237669A (en) | 1992-08-26 |
| DE69121240T2 (de) | 1997-01-09 |
| GR3021478T3 (en) | 1997-01-31 |
| NO307341B1 (no) | 2000-03-20 |
| ES2093100T3 (es) | 1996-12-16 |
| FI108037B (fi) | 2001-11-15 |
| ZA912489B (en) | 1992-01-29 |
| SA92120348B1 (ar) | 2004-01-24 |
| CA2080018C (en) | 2003-10-14 |
| FI924575A0 (fi) | 1992-10-09 |
| US5440017A (en) | 1995-08-08 |
| KR100212371B1 (ko) | 1999-08-02 |
| IL97775A0 (en) | 1992-06-21 |
| NO923918L (no) | 1992-12-01 |
| EP0527813A4 (en) | 1993-05-05 |
| FI924575A (fi) | 1992-10-09 |
| ATE141105T1 (de) | 1996-08-15 |
| CA2080018A1 (en) | 1991-10-14 |
| PT97355A (pt) | 1991-12-31 |
| DK0527813T3 (da) | 1996-12-30 |
| NO923918D0 (no) | 1992-10-08 |
| US5312733A (en) | 1994-05-17 |
| IE911250A1 (en) | 1991-10-23 |
| AU664535B2 (en) | 1995-11-23 |
| EP0527813A1 (en) | 1993-02-24 |
| IL97775A (en) | 1998-04-05 |
| IE75903B1 (en) | 1997-10-08 |
| EP0527813B1 (en) | 1996-08-07 |
| JPH05506989A (ja) | 1993-10-14 |
| DE69121240D1 (de) | 1996-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0527813A4 (en) | Novel t-cell lymphoma cdna clones | |
| RU2346951C2 (ru) | Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты) | |
| DE69535375D1 (de) | Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper | |
| UA40621C2 (uk) | Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла | |
| CA2164984A1 (en) | Recombinant disulfide-stabilized polypeptide fragments having binding specificity | |
| EP0281604A4 (en) | BINDING MOLECULES WITH SINGLE POLYPEPTIDE CHAIN. | |
| IL193886A (en) | Antibodies that bind to ldcam sequences | |
| EP0590071A4 (en) | Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof | |
| Nolan et al. | Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement | |
| IL98024A0 (en) | Cd44-surface proteins,dna-sequences coding therefor,polypeptides coded by said dna sequences and diagnostic compositions containing the same | |
| CA2461443A1 (en) | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use | |
| GR3035636T3 (en) | Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules | |
| TW200716746A (en) | Methods for identifying a compound modulating the binding between polypeptides | |
| AU5508396A (en) | Pcna binding substance | |
| AU5124993A (en) | Peptide diagnostics and therapeutics for spondyloarthropathies | |
| WO1996023884A3 (en) | Human peroxisome proliferator activated receptors | |
| ATE247164T1 (de) | Insulinartigen wachstumsfaktor bindendes protein | |
| ATE212056T1 (de) | Methoden zur herstellung von rna viren aus cdna | |
| ATE281519T1 (de) | Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor) | |
| MacLeod | T-cell lymphoma CDNA clones | |
| CA2180957A1 (en) | Cloning and recombinant production of crf receptor(s) | |
| Zhang et al. | Primary structure of myohemerythrin from Phascolopsis gouldii | |
| AR041564A1 (es) | Genes aislados de proteinas de membrana de mamiferos reactivos relacionados | |
| EP1820859A3 (en) | Methods and compositions for inhibiting neoplastic cell growth | |
| CONNORS | PROPERTIES OF PREALBUMIN IN HEREDOFAMILIAL AMYLOIDOSIS (TRANSTHYRETIN) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20040412 |
|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |